P04.22 Diffusivity changes in bevacizumab-responding and refractory meningioma

per Roelcke, U., Berberat, J., Mamot, C., Remonda, L.
Publicat a Neuro Oncol (2017)

P04.25 Susceptibility-weighted MRI to predict recurrence of glioblastoma

per van Leyen, K., Berberat, J., Remonda, L., Roelcke, U.
Publicat a Neuro Oncol (2017)

Influence of spinal cord injury on cerebral sensorimotor systems: a PET study.

per Roelcke, U, Curt, A, Otte, A, Missimer, J, Maguire, R P, Dietz, V, Leenders, K L
Publicat 1997

P17.41 CLINICAL MANAGEMENT AND OUTCOME OF HISTOLOGICALLY VERIFIED ADULT BRAINSTEM GLIOMAS IN SWITZERLAND: A RETROSPECTIVE ANALYSIS OF 21 PATIENTS

per Hundsberger, T., Tonder, M., Andreas, H., Brügge, D., Roelcke, U., Putora, P.M., Stupp, R., Weller, M.
Publicat 2014

P18.01 COMPLEMENTARY THERAPY USE IN A COHORT OF SWISS GLIOMA PATIENTS

per Eisele, G., Roelcke, U., Conen, K., Huber, F., Weiss, T., Hofer, S., Heese, O., Westphal, M., Weller, M.
Publicat 2014

P01.108 Use of complementary and alternative medicine in glioma patients

per Hertler, C, Roelcke, U, Conen, K, Huber, F, Weiss, T, Hofer, S, Heese, O, Westphal, M, Roth, P, Weller, M, Eisele, G
Publicat a Neuro Oncol (2018)

Operated low grade astrocytomas: a long term PET study on the effect of radiotherapy

per Roelcke, U, von Ammon, K, Hausmann, O, Kaech, D, Vanloffeld, W, Landolt, H, Rem, J, Gratzl, O, Radu, E, Leenders, K
Publicat 1999

Effect of radiotherapy on brain glucose metabolism in patients operated on for low grade astrocytoma

per Bruehlmeier, M, Roelcke, U, Amsler, B, Schubert, K, Hausmann, O, von Ammon, K, Radu, E, Gratzl, O, Landmann, C, Leenders, K
Publicat 1999

OS07.2 Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the ARTE trial

per Wirsching, H. G., Tabatabai, G., Hottinger, A., Plasswilm, L., Roelcke, U., Conen, K., Held, L., Rushing, E. J., Ochsenbein, A., Weller, M.
Publicat a Neuro Oncol (2017)